Results
|
|
41.
|
|
|
|
42.
|
|
|
|
43.
|
|
|
|
44.
|
|
|
|
45.
|
|
|
|
46.
|
|
|
|
47.
|
|
|
|
48.
|
|
|
|
49.
|
|
|
|
50.
|
|
|
|
51.
|
|
|
|
52.
|
|
|
|
53.
|
|
|
|
54.
|
|
|
|
55.
|
|
|
|
56.
|
|
|
|
57.
|
|
|
|
58.
|
|
|
|
59.
|
|
|
|
60.
|
Brimonidine gel 0.33% rapidly improves patient-reported outcomes by controlling facial erythema of rosacea: a randomized, double-blind, vehicle-controlled study. [electronic resource] by
- Layton, A M
- Schaller, M
- Homey, B
- Hofmann, M A
- Bewley, A P
- Lehmann, P
- Nohlgård, C
- Sarwer, D B
- Kerrouche, N
- Ma, Y M
Producer: 20161014
In:
Journal of the European Academy of Dermatology and Venereology : JEADV vol. 29
Availability: No items available.
|